Medications
FDA rejects MDMA-assisted therapy for PTSD treatment—a researcher explains the challenges psychedelics face
Drugmaker Lykos Therapeutics announced on Aug. 9, 2024, that the Food and Drug Administration declined to approve the company's application for the use of MDMA-assisted therapy in the treatment of post-traumatic stress disorder. ...
Aug 13, 2024
0
1